- OA-CL-LYM-LYSARC-13134C

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2091220388

Enrollment

Registered

2018-09-27

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention type:DRUG Name of intervention: Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration:100~300 mg Dosing freque

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Countries

Austria, Belgium, Denmark, France, Italy, Japan, South Korea, United Kingdom

Outcome results